According to Stoke Therapeutics's latest financial reports the company's current revenue (TTM) is £11.54 M. In 2023 the company made a revenue of £6.89 M a decrease over the revenue in the year 2022 that were of £10.25 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.